FY24 consensus $9.84. Raises FY24 operational revenue view to $89.4B-$89.8B from $89.2B-$89.6B, consensus $88.51B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Notable companies reporting before tomorrow’s open
- Eli Lilly’s (NYSE:LLY) Crohn’s Disease Drug Outperforms JNJ’s Version
- Options Volatility and Implied Earnings Moves This Week, October 15 – October 18, 2024
- Johnson & Johnson (JNJ) Q3 Pre-Earnings: Here’s What to Expect
- Johnson & Johnson (JNJ) Q3 Earnings Cheat Sheet